Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies

Bibliographic Details
Main Authors:	Carlos Pérez-Plasencia, Teresita Padilla-Benavides, Eduardo López-Urrutia, Alma D. Campos-Parra
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Oncology
Subjects:	repurposed drugs cancer oncologic therapies cancer research clinical insights
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.713040/full

Similar Items

Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses
by: Eduardo López-Urrutia, et al.
Published: (2021-10-01)

Editorial: Drug Repurposing
by: Pan Pantziarka, et al.
Published: (2019-07-01)

“Hard” Drug Repurposing for Precision Oncology: The Missing Link?
by: Pan Pantziarka, et al.
Published: (2018-06-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
by: Marike W. van Gisbergen, et al.
Published: (2021-05-01)

Pathway-Based Drug-Repurposing Schemes in Cancer: The Role of Translational Bioinformatics
by: Enrique Hernández-Lemus, et al.
Published: (2021-01-01)

Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
by: Andrea Emanuele Guerini, et al.
Published: (2019-08-01)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
by: Monserrat Llaguno-Munive, et al.
Published: (2021-02-01)

Drug combination and repurposing for cancer therapy: the example of breast cancer
by: Ana Salomé Correia, et al.
Published: (2021-01-01)

Prospects for repurposing CNS drugs for cancer treatment
by: Mohamed Abdelaleem, et al.
Published: (2019-04-01)

Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
by: Ahmed Olatunde, et al.
Published: (2021-09-01)

Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions
by: Eleni Sertedaki, et al.
Published: (2020-05-01)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
by: Rita Rebelo, et al.
Published: (2021-03-01)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
by: Borcherding N, et al.
Published: (2020-11-01)

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
by: Jennifer H. Martin, et al.
Published: (2019-12-01)

Repurposing Infectious Diseases Vaccines Against Cancer
by: Liese Vandeborne, et al.
Published: (2021-05-01)

Repurposing of a muscle relaxant drug thiocolchicoside as an anticancer agent
by: Shreya Medhi, et al.
Published: (2021-01-01)

Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
by: Filipa Moreira-Silva, et al.
Published: (2020-04-01)

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
by: Christina Pfab, et al.
Published: (2021-06-01)

Repurposing of Drug Candidates for Treatment of Skin Cancer
by: Hernán Cortés, et al.
Published: (2021-01-01)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
by: Bárbara Costa, et al.
Published: (2021-05-01)

Targeting BRF2 in Cancer Using Repurposed Drugs
by: Behnam Rashidieh, et al.
Published: (2021-07-01)

Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy
by: Michel Montalvo-Casimiro, et al.
Published: (2020-11-01)

Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development
by: Jan eStenvang, et al.
Published: (2013-12-01)

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
by: Marika Mokou, et al.
Published: (2020-11-01)

Editorial: Drug Repurposing for COVID-19 Therapy
by: Rafael Maldonado, et al.
Published: (2021-08-01)

Drug Repurposing for the Treatment of Acute Myeloid Leukemia
by: Vibeke Andresen, et al.
Published: (2017-11-01)

Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
by: Riccardo Giampieri, et al.
Published: (2020-09-01)

Drug Repurposing for Triple-Negative Breast Cancer
by: Marta Ávalos-Moreno, et al.
Published: (2020-10-01)

Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer Therapy
by: Sharavan Ramachandran, et al.
Published: (2020-12-01)

DeCoST: A New Approach in Drug Repurposing From Control System Theory
by: Thanh M. Nguyen, et al.
Published: (2018-06-01)

IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics
by: Jennifer D. Hintzsche, et al.
Published: (2018-04-01)

OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs
by: Richard E. Kast, et al.
Published: (2021-05-01)

Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
by: Feng Yang, et al.
Published: (2021-01-01)

Connecting Chemical and Omics Domains for Drug Discovery and Repurposing
by: Reigle, James K., M.S.
Published: (2021)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
by: Beste Turanli, et al.
Published: (2019-05-01)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
by: Maria João Gouveia, et al.
Published: (2018-02-01)

Drug repurposing: Iron in the fire for older drugs
by: H.V. Sonaye, et al.
Published: (2021-09-01)

Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
by: Bernhard W. Renz, et al.
Published: (2017-06-01)

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells
by: Sandipan Datta, et al.
Published: (2021-01-01)